Bio-Techne Bio-Techne is a company that provides researchers in life science and clinical diagnostics with reagent instruments, custom manufacturing, and testing services. | Humanigen Humanigen is repositioning and developing its proprietary monoclonal antibodies to meet some critical unmet needs in cancer science. | LGC LGC is a life science tools company providing components and solutions for high-growth application areas. | ||
Founding Date | Founding Date 2002 | Founding Date 1981 | Founding Date 2000 | Founding Date 1842 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations San Diego, US HQ Beijing, CN Koblenz, DE Bunkyo City, JP Amsterdam, NL London, GB | Locations Minneapolis, US HQ Toronto, CA Praha, CZ Copenhagen, DK Noyal Châtillon Sur Seiche, FR Noyal Châtillon Sur Seiche, FR Planegg, DE see more | Locations Burlingame, US HQ Dublin, IE London, GB Kansas City, US | Locations Teddington, GB HQ São José Dos Campos, BR Sofia, BG Milton, CA Pointe Claire, CA Toronto, CA Beijing, CN see more |
Employees | Employees 6691% increase | Employees 3,0502% increase | Employees 233% decrease | Employees 1,00814% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11.6 b | Valuation ($) 4.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.2b (FY, 2024) | Revenue (est.) $2.5m (FY, 2022) | Revenue (est.) £142.5m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $389.3m (FY, 2024) | Cost of goods N/A | Cost of goods £88.7m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $769.7m (FY, 2024) | Gross profit N/A | Gross profit £53.8m (FY, 2023) |
Net income | Net income N/A | Net income $168.1m (FY, 2024) | Net income ($70.7m) (FY, 2022) | Net income £21.3m (FY, 2023) |
Operating ⚠ | ||||
Patent Applications | Patent Applications N/A | Patent Applications 270 (FY, 2022) | Patent Applications 17 (FY, 2017) | Patent Applications N/A |